Metis Global Partners, LLC Jazz Pharmaceuticals PLC Transaction History

Metis Global Partners, LLC

  • $3.16 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024
BUY
$115.19 - $132.77 $2,534 - $2,920
22 Added 1.0%
2,225 $267,000
Q4 2023

Feb 06, 2024
SELL
$114.26 - $136.0 $7,998 - $9,520
-70 Reduced 3.08%
2,203 $270,000
Q3 2023

Nov 07, 2023
BUY
$122.0 - $145.31 $6,222 - $7,410
51 Added 2.3%
2,273 $294,000
Q2 2023

Aug 07, 2023
BUY
$122.5 - $147.16 $45,570 - $54,743
372 Added 20.11%
2,222 $275,000
Q1 2023

May 08, 2023
BUY
$133.98 - $160.47 $247,862 - $296,869
1,850 New
1,850 $270,000

Others Institutions Holding JAZZ

# of Institutions
512
Shares Held
57.5M
Call Options Held
188K
Put Options Held
133K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Metis Global Partners, LLC Portfolio

Follow Metis Global Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metis Global Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Metis Global Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email